CHICAGO, June 15, 2017 -- Procured Health, a leader in providing health systems with solutions that improve patient outcomes and operational efficiency, announced two key appointments today. Michael Blaszyk will join the firm’s board of directors while Egon Doppenberg, MD, will serve on the company’s Physician Advisory Council.
Blaszyk brings decades of healthcare leadership experience to the Procured Health board. Before retiring in 2015, he served as senior executive vice president, CFO and chief corporate officer of San Francisco–based Dignity Health. During his 15 years in that role, he helped the organization grow from a $6 billion hospital company to a $17 billion integrated delivery system.
“I firmly believe in Procured Health’s mission of using clinical evidence to help health system leaders make decisions that are based on proven cost benefits rather than subjective experiences and personal preferences,” Blaszyk said. “I look forward to offering strategic guidance as the company continues to develop innovative solutions to eliminate unnecessary costs.”
Doppenberg also brings deep experience to Procured Health, where, as a member of the Physician Advisory Council, he will provide practical, field-based insights to support the firm’s evidence-based research. A board-certified neurosurgeon, Doppenberg currently serves as associate medical director of neurosurgery and medical director of spinal surgery at Illinois-based Advocate Medical Group. In 2014, he was named one of Becker’s Spine Review’s “Surgeon Leaders to Know.”
“I’ve witnessed first-hand the opportunities for reducing unnecessary clinical variation that the Procured Health team provides,” Doppenberg said. “They speak an evidence-based, data-driven language that physicians understand and they recognize the importance of cross-departmental collaboration to achieve sustainable savings. I’m excited to contribute to those conversations.”
The addition of Blaszyk and Doppenberg strengthens Procured Health’s goal of driving significant and lasting change in healthcare. “Having two such highly respected leaders join us is a testament to the work we’ve done and what we plan to accomplish in the future,” said Procured Health CEO Hani Elias. “The amount of wasteful spending and unnecessary variation within the healthcare industry is staggering. We’re eager to tap into Mr. Blaszyk’s and Dr. Doppenberg’s knowledge and passion as we push our clients to think differently about how to solve these problems.”
About Procured Health
Procured Health is at the forefront of helping health systems achieve the best clinical outcomes at an optimal cost. Providers across the U.S. rely on Procured Health's technology platform to make better decisions on spend and usage of medical devices, supplies, and drugs.
For more information, visit ProcuredHealth.com, find us on LinkedIn, follow @ProcuredHealth on Twitter and like us on Facebook.
Procured Health [email protected] (312) 300-7899


FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Bill Ackman Eyes New Fund to Bet Against Market Complacency 



